Quality and liability issues with the Papanicolaou smear: The problem of definition of errors and false-negative smears

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 3, 1997, Pages 267-269

  Davey, Diane D ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CONFERENCE PAPER; DIAGNOSTIC ERROR; DYSPLASIA; HEALTH CARE FINANCING; HUMAN; HUMAN CELL; INSURANCE; LAW SUIT; PAPANICOLAOU TEST; QUALITY CONTROL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LIABILITY, LEGAL; PREDICTIVE VALUE OF TESTS; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030937594     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Naryshkin S, Davey DD. Terminology of false negative and false positive Pap smears: "they're just worms." Diagn Cytopathol. 1996;14-1-3.
2. Voelkner R. Milwaukee deaths reignite critical issues in cervical cancer screening. JAMA. 1995;278:1159-1160.
3. Department of Health and Human Services. Improving the Quality of Clinician Pap Smear Technique and Management, Client Pap Smear Education, and the Evaluation of Pap Smear Laboratory Testing: A Resource Guide for Title X Family Planning Projects. Washington, DC. US Dept of Health and Human Services; 1939.
4. Gay JD, Donaldson LD, Goellner JR. false negative results in cervical cytologic studies. Acta Cytol. 1985;29:1043-1046.
5. Richart RM, Vaillant H. Influence of cell collection techniques upon cytological diagnosis. Cancer. 1965;18:1474-1478.
6. Elias A, Linthorst G, Bekker B, Vooijs PG. The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol. 1983;27:225-229.
7. DeMay RM. The Pap smear. In: The Art & Science of Cytopathology. Chicago, Ill: ASCP Press; 1996:141-143.
8. Vooijs GP. Opinion poll on quality assurance and quality control. Acta Cytol. 1996;40:14-24.
9. Bosch MMC. Rietveld-Scheffers PEM, Boon ME. Characteristics of false negative smears in the normal screening situation. Acta Cytol. 1992;35:711-716.
10. Mitchell H, Medley G. Differences between Papanicolaou smears with correct and incorrect diagnoses. Cytopathology. 1995;6:368-375.
11. Clinical Laboratory Improvement Amendments of 1988; final rule. Federal Register. 1992;57:7169.
12. Kim HS, Underwood D. Adenocarcinomas in the cervicovaginal Papanicolaou smear: analysis of a 12-year experience. Diagn Cytopathol. 1991;7:119-124.
13. Robb JA. The "ASCUS" swamp. Diagn Cytopathol. 1994;11:319-320.
14. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol. 1994;102:182-187.
15. Sherman ME, Kelly D. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? Mod Pathol. 1992;5:337-342.
16. Spires SE, Banks ER, Weeks JA, Banks HW, Davey DD. Assessment of cervicovaginal smear adequacy: the Bethesda System guidelines and reproducibility. Am J Clin Pathol. 1994;102:354-359.
17. Jones BA, Novis DA. Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120:523-531.
18. Allen KA, Zaleski S, Cohen MB. Review of negative Papanicolaou tests: is the retrospective 5-year review necessary? Am J Clin Pathol. 1994;101:19-21.
19. Jones BA. Rescreening in gynecologic cytology: rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma - a College of American Pathologists Q-Probes study of 312 institutions. Arch Pathol Lab Med. 1995;119:1097-1103.
20. Krieger P, Naryshkin S. Terminology, benchmarking and reporting in cervical cytology automation: the critical need for consistency. Acta Cytol. 1996;40:9-11. Editorial.
21. Wied GE, Bartels PH, Bibbo M, et al. Computer-assisted quality assurance. Acta Cytol. 1996;40:1-3. Editorial.
22. Davey DD, Nielsen ME, Frable WJ, Rosenstock W, Lowell DM, Kraemer BB. Improving accuracy in gynecologic cytology: results of the College of American Pathologists interlaboratory Comparison Program in Cervicovaginal Cytology (PAP). Arch Pathol Lab Med. 1993;117:1193-1198.
23. Interlaboratory Comparison Program in Cervicovaginal Cytology (PAP): 1994 PAP Year End Summary. Northfield, Ill: College of American Pathologists; 1995.
24. Hatem F, Wilbur DC. High grade squamous cervical lesions following negative Papanicolaou smears: false-negative cervical cytology or rapid progression. Diagn Cytopathol. 1995;12:135-141.
25. Krieger P, Naryshkin S. Random rescreening of cytology smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories. Acta Cytol. 1994;38:291-298. Guest Editorial.
26. Naryshkin S. The false-negative fraction for Papanicolaou Smears: How often are "abnormal" smears not detected by a "standard" screening cytologist? Arch Pathol Lab Med. 1997;121-270-272.